Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Delaporte

Showing results (311-320 of 328) with videos related to

Pageof 33
Sort By:
AIDS (London, England)|March 31, 1998
Is it necessary to conduct trials with trimethoprim-sulphamethoxazole amongst HIV-infected individuals in Africa?B Samb, M Badiane, S Kony, et al.
Journal of Virology|February 1, 1997
Molecular epidemiology of 58 new African human T-cell leukemia virus type 1 (HTLV-1) strains: identification of a new and distinct HTLV-1 molecular subtype in Central Africa and in PygmiesR Mahieux, F Ibrahim, P Mauclere, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 6, 2001
Evaluation of two commercial kits for the detection of genotypic drug resistance on a panel of HIV type 1 subtypes A through JE Fontaine, C Riva, M Peeters, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 22, 2016
Predictors of long-term drug survival for infliximab in psoriasisQ Magis, D Jullien, C Gaudy-Marqueste, et al.
Journal of Medical Virology|June 14, 2008
Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study)H Diop-Ndiaye, C Touré-Kane, J F Etard, et al.
AIDS Research and Human Retroviruses|October 9, 1998
Molecular characterization of the envelope transmembrane glycoprotein of 13 new human immunodeficiency virus type 1 group O strains from six different African countriesF Bibollet-Ruche, M Peeters, S Mboup, et al.
Dermatology (Basel, Switzerland)|December 24, 2009
Clinicopathological study of 13 cases of squamous cell carcinoma complicating hidradenitis suppurativaC Lavogiez, E Delaporte, S Darras-Vercambre, et al.
Pharmacoeconomics - Open|July 6, 2019
Cost-Effectiveness of Three Alternative Boosted Protease Inhibitor-Based Second-Line Regimens in HIV-Infected Patients in West and Central AfricaS Boyer, M L Nishimwe, L Sagaon-Teyssier, et al.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|September 17, 2009
Tenofovir-emtricitabine-efavirenz in HIV-I-infected adults in Senegal: a 96-week pilot trial in treatment-naive patientsRoland Landman, M Poupard, M Diallo, et al.
AIDS (London, England)|July 1, 1996
Epidemiological and molecular characteristics of HIV infection in Gabon, 1986-1994E Delaporte, W Janssens, M Peeters, et al.
Pageof 33

Showing results (311-320 of 328) with videos related to

Sort By:
Pageof 33
AIDS (London, England)|March 31, 1998
Is it necessary to conduct trials with trimethoprim-sulphamethoxazole amongst HIV-infected individuals in Africa?B Samb, M Badiane, S Kony, et al.
Journal of Virology|February 1, 1997
Molecular epidemiology of 58 new African human T-cell leukemia virus type 1 (HTLV-1) strains: identification of a new and distinct HTLV-1 molecular subtype in Central Africa and in PygmiesR Mahieux, F Ibrahim, P Mauclere, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 6, 2001
Evaluation of two commercial kits for the detection of genotypic drug resistance on a panel of HIV type 1 subtypes A through JE Fontaine, C Riva, M Peeters, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 22, 2016
Predictors of long-term drug survival for infliximab in psoriasisQ Magis, D Jullien, C Gaudy-Marqueste, et al.
Journal of Medical Virology|June 14, 2008
Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study)H Diop-Ndiaye, C Touré-Kane, J F Etard, et al.
AIDS Research and Human Retroviruses|October 9, 1998
Molecular characterization of the envelope transmembrane glycoprotein of 13 new human immunodeficiency virus type 1 group O strains from six different African countriesF Bibollet-Ruche, M Peeters, S Mboup, et al.
Dermatology (Basel, Switzerland)|December 24, 2009
Clinicopathological study of 13 cases of squamous cell carcinoma complicating hidradenitis suppurativaC Lavogiez, E Delaporte, S Darras-Vercambre, et al.
Pharmacoeconomics - Open|July 6, 2019
Cost-Effectiveness of Three Alternative Boosted Protease Inhibitor-Based Second-Line Regimens in HIV-Infected Patients in West and Central AfricaS Boyer, M L Nishimwe, L Sagaon-Teyssier, et al.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|September 17, 2009
Tenofovir-emtricitabine-efavirenz in HIV-I-infected adults in Senegal: a 96-week pilot trial in treatment-naive patientsRoland Landman, M Poupard, M Diallo, et al.
AIDS (London, England)|July 1, 1996
Epidemiological and molecular characteristics of HIV infection in Gabon, 1986-1994E Delaporte, W Janssens, M Peeters, et al.
Pageof 33